National Infusion Center Association
The NICA Accreditation Program and the National Infusion Center Association are proud to announce that Intrafusion by McKesson, Neurological Sciences of Orlando (NSO) has earned the […]
The NICA Accreditation Program and the National Infusion Center Association are proud to announce that Ivira Infusions has earned the National Infusion Center Association (NICA) Accreditation […]
The National Infusion Center Association (NICA), the Global Colon Cancer Association (GCCA), and the Pharmaceutical Research and Manufacturers of America (PhRMA) filed a complaint in U.S. […]
The National Infusion Center Association (NICA) announces its collaboration with COSACO, a community health organization based in Puerto Rico, to improve access to COVID-19 monoclonal antibody […]
“Tracking Down Antibody Treatment Is A Challenge For COVID-19 Patients” This article describes an active 80-year-old woman’s experience searching for monoclonal antibody drugs to treat her […]
“Q&A: Monoclonal Antibodies for COVID-19” In this Q&A interview with Jason C. Gallagher, PharmD, Clinical Professor and Clinical Specialist at Temple University, NICA is mentioned as […]
“Experimental COVID-19 treatment aimed at keeping Ventura County residents out of hospitals” NICA President and CEO, Brian Nyquist, is quoted in this article expressing the importance […]
“Powerful New Tool Predicts COVID Trends” This article explores predictive analytics for predicting COVID-19 surges, and NICA is mentioned as one of the organizations helping to […]
“Lower valley hospital sees success with COVID-19 antibody treatments” This article explains how one local hospital in Sunnyside, Washington successful administered monoclonal antibodies to COVID-positive patients. […]
